Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Residency Update

30 Jan 2018 07:00

RNS Number : 2599D
Phoenix Group Holdings
30 January 2018
 

Phoenix Group Holdings

LEI: 21380031B1D56JRCE375

Notice to PGH shareholders and to holders of outstanding debt securities regarding change in the head office and tax residence of Phoenix Group Holdings ("PGH")

Further to the announcement dated 21 June 2017, notice is hereby given that with effect from 31 January 2018 the central management and control, and the head office, of PGH will move from Jersey to the United Kingdom, with the intention that PGH will be resident in the United Kingdom for tax purposes from such date.

With effect from 31 January 2018, the PRA will treat PGH, and not Phoenix Life Holdings Limited ("PLHL"), as the ultimate EEA insurance holding company of the Insurance Group.

Holders of the subordinated securities:

· £428,113,000 6.625 per cent. Guaranteed Subordinated Notes due 2025;

· £450,000,000 4.125 per cent. Tier 3 Notes due 2022 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme; and

· U.S.$500,000,000 5.375 per cent. Notes due 2027 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme,

each issued by PGH (together, the "Outstanding Subordinated Securities"), are hereby notified that as such, PGH will become the ultimate EEA insurance holding company and the Insurance Group Parent Entity and a member of the Insurance Group for the purposes of the terms and conditions of the Outstanding Subordinated Securities. This will result in the Outstanding Subordinated Securities (and not the relevant on-loan of the proceeds of the Outstanding Subordinated Securities) being the only relevant capital item for the purposes of the definition of "Capital Disqualification Event" under the Outstanding Subordinated Securities with effect from such date.

PLHL will no longer be required by the PRA to be taken into account for the purposes of the deferral of principal and interest on the Outstanding Subordinated Securities pursuant to the definitions of "Regulatory Deficiency Interest Deferral Event" and "Regulatory Deficiency Redemption Deferral Event".

Capitalised terms that are not defined in this announcement will have the meanings given to them in the terms and conditions of the Outstanding Subordinated Securities.

The change in tax residency is not expected to impact PGH shareholders, other than UK stamp duty reserve tax (currently levied at 0.5%) will be incurred on subsequent purchases of PGH depositary interests.

Any PGH shareholder who is uncertain of the implications of the change in PGH's tax residency on their investment is recommended to obtain professional advice.

The change in tax residency will not impact the terms and conditions of the £300,000,000 5.75 per cent. Bonds due 2021 (of which £121,610,000 remains outstanding).

For further information, please contact:

 

Debt investors:

Rashmin Shah, Group Treasurer, Phoenix Group

Telephone: +44 (0) 20 3735 0059

Email: rashmin.shah@thephoenixgroup.com

 

Equity investors/analysts:Sam Perowne, Head of Investor Relations, Phoenix GroupTelephone: +44 (0) 20 3735 0021

Email: Samuel.Perowne@thephoenixgroup.com

 

 

Website: www.thephoenixgroup.com

 

This notice does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEDFWUFASEDF
Date   Source Headline
17th May 20216:15 pmRNSHolding(s) in Company
14th May 20212:15 pmRNSResult of AGM
13th May 20219:00 amRNSDirector/PDMR Shareholding
30th Apr 202111:45 amRNSTotal Voting Rights
13th Apr 20211:00 pmRNSDirector/PDMR Shareholding
7th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 202112:00 pmRNSDirector/PDMR Shareholding
31st Mar 20212:00 pmRNSTotal Voting Rights
31st Mar 20212:00 pmRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
29th Mar 20214:40 pmRNSNotice of AGM
24th Mar 20214:15 pmRNSDirector/PDMR Shareholding
19th Mar 202111:30 amRNSDirector/PDMR Shareholding
18th Mar 202110:00 amRNSHolding(s) in Company
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20214:30 pmRNSDirector/PDMR Shareholding
8th Mar 20213:15 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNS2020 Annual Financial Results
26th Feb 20212:00 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPhoenix and SLA simplify Strategic Partnership
23rd Feb 20217:00 amRNSUpdate on Strategic Partnership with PGH
8th Feb 20216:00 pmRNSDirector/PDMR Shareholding
29th Jan 20213:30 pmRNSTotal Voting Rights
21st Jan 20214:45 pmRNSHolding(s) in Company
8th Jan 20213:10 pmRNSDirector/PDMR Shareholding
31st Dec 202011:00 amRNSTotal Voting Rights
29th Dec 202010:45 amRNSHolding(s) in Company
24th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20203:30 pmRNSBlock listing Return
11th Dec 20202:45 pmRNSDirector/PDMR Shareholding
9th Dec 20204:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSPhoenix Group Holdings plc - Trading Update
30th Nov 20204:00 pmRNSTotal Voting Rights
24th Nov 20207:00 amRNSStatement Regarding Press Speculation
6th Nov 20205:30 pmRNSDirector/PDMR Shareholding
6th Nov 20204:15 pmRNSDirector/PDMR Shareholding
30th Oct 202012:30 pmRNSTotal Voting Rights
28th Oct 20205:30 pmRNSDirector/PDMR Shareholding
28th Oct 202010:30 amRNSNotice of Delisting of Restricted Tier 1 Notes
27th Oct 20202:48 pmRNSNotice of Variation and Relisting of Notes
14th Oct 20209:40 amRNSHolding(s) in Company
7th Oct 202012:15 pmRNSDirector/PDMR Shareholding
7th Oct 202012:15 pmRNSDirector/PDMR Shareholding
6th Oct 202012:45 pmRNSDirector/PDMR Shareholding
1st Oct 20201:00 pmRNSDirector/PDMR Shareholding
30th Sep 202012:20 pmRNSTotal Voting Rights
25th Sep 202011:45 amRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.